Hydroxylated silica and alumina surface

Hydroxylated silica and alumina surfaces are inorganic interfaces characterized by silanol (Si-OH) and aluminol (Al-OH) functional groups. These surfaces are not classical therapeutic targets like receptors or enzymes but play significant roles in drug delivery, vaccine formulation, and pathology. In a biological context, these hydroxylated groups interact with biomolecules through hydrogen bonding and electrostatic interactions, influencing protein folding and membrane integrity (Pavan et al., 2014, PubMed: 24911544). Crystalline silica surfaces are known to trigger the NLRP3 inflammasome in macrophages, leading to the release of pro-inflammatory cytokines and the development of silicosis (Hornung et al., 2008, PubMed: 18604214). Conversely, hydroxylated alumina is frequently utilized as a vaccine adjuvant to enhance the immune response by promoting antigen uptake and activating innate immune pathways (Ghimire, 2015, PubMed: 25583474). In nanomedicine, mesoporous silica surfaces are engineered for controlled drug release, where the degree of hydroxylation dictates the loading efficiency of various therapeutic agents (Manzano & Vallet-Regí, 2020, PubMed: 31991616). Safety concerns primarily involve the generation of reactive oxygen species (ROS) and the potential for chronic fibrotic responses upon inhalation of silica dust (Mossman & Glenn, 2013, PubMed: 23843420). Overall, these surfaces represent a critical interface between inorganic materials and biological systems, necessitating careful characterization for medical applications.

Other names

Silanol-rich silicaHydroxylated aluminum oxideSilica surfaceAlumina surfaceSi-OH and Al-OH surfacesHydrated silicaHydrated alumina

Surface-mediated hydrogen bonding and electrostatic interactions with biomolecules; activation of the NLRP3 inflammasome via phagolysosomal rupture; generation of reactive oxygen species (ROS) leading to cellular oxidative stress.